Tonix Pharmaceuticals Doses First Patient

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates What are the potential long-term implications of TNX-102 SL for individuals experiencing acute stress reaction (ASR) and acute stress disorder (ASD)? “`html The battlefield isn’t just a place; it’s a moment that imprints itself on the mind, leaving scars that can linger long after … Read more

Tonix Pharmaceuticals Announces First Patient Dosed in

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the University of North Carolina (UNC) and supported by a grant from the U.S. Department of Defense Topline results from the trial are expected in the second … Read more